GLP1R and myocardial infarction: Hence, the reduction in non-fatal myocardial infarction detected with liraglutide is unlikely to be explained solely by GLP-1 receptor-mediated actions; A better understanding of how GLP-1R activation reduces the risk of myocardial infarction and cardiovascular death is needed.